Salivary Metabolomics in Cancer Diagnosis

Salivary metabolomics has emerged as a powerful and non-invasive approach for cancer detection, leveraging the diverse array of small molecules present in saliva to reflect both local tumour activity and systemic metabolic alterations. Owing to its ease of collection, minimal requirement for professional handling and suitability for repeated sampling, saliva offers an attractive matrix for early screening, risk stratification and monitoring of therapeutic response. Analytical platforms such as nuclear magnetic resonance spectroscopy, capillary electrophoresis–mass spectrometry and liquid chromatography–mass spectrometry enable comprehensive profiling of amino acids, polyamines, lipids and other metabolites. Studies to date have revealed distinct salivary signatures associated with oral squamous cell carcinoma, pancreatic malignancies and other tumours, often linked to aberrant energy metabolism, fatty acid synthesis and polyamine pathways. Key challenges include standardising collection and storage protocols, controlling for diurnal and dietary variability and validating candidate biomarkers in large, diverse cohorts. Integration with other ‘omics’ layers, application of advanced data-analysis tools and development of point-of-care devices promise to advance salivary metabolomics towards routine clinical implementation, particularly in resource-limited settings where early, affordable screening can have the greatest impact.

Research from Nature Portfolio

Identification of salivary metabolomic biomarkers for oral cancer screening demonstrated that comprehensive profiling of both tumour tissue and unstimulated saliva can eliminate coincidental differences and pinpoint genuine disease-associated metabolites. A panel of 17 consistently altered metabolites was identified, and a minimal combination of two salivary markers achieved high discriminatory performance, indicating strong potential for non-invasive oral cancer screening.
Effect of storage conditions on salivary polyamines quantified via liquid chromatography–mass spectrometry evaluated the stability of polyamine and amino acid profiles under varied temperature and duration settings. Polyamines proved more resilient than amino acids at elevated temperatures, while addition of ethanol further stabilised key metabolites. Computational simulations confirmed that the discriminative power of salivary polyamines for pancreatic cancer remains robust across realistic handling variations, underpinning protocol standardisation for reliable clinical assays.

Salivary Metabolomics in Cancer Diagnosis publication trend

The graph below shows the total number of articles in salivary metabolomics in cancer diagnosis across all publications each year (not limited to Nature Index journals).

Technical terms

Metabolomics: The large-scale study of small molecules (metabolites) within biological samples to characterise metabolic states.

Biomarker: A measurable indicator of a biological condition, often used for diagnosis, prognosis or monitoring of disease.

Liquid chromatography–mass spectrometry (LC-MS): An analytical technique combining liquid chromatography for separation with mass spectrometry for sensitive detection and quantification of metabolites.

Capillary electrophoresis–mass spectrometry (CE-MS): An analytical method integrating capillary electrophoresis separation with mass spectrometry detection, offering high resolution for charged metabolites.

Polyamines: Organic compounds containing two or more amino groups, involved in cell growth and differentiation and studied as potential cancer biomarkers in saliva.

References

1. Identification of salivary metabolomic biomarkers for oral cancer screening. Scientific Reports (2016).
2. Effect of storage conditions on salivary polyamines quantified via liquid chromatography-mass spectrometry. Scientific Reports (2018).
3. Development and validation of a non-invasive method for quantifying amino acids in human saliva. RSC Advances (2024).
4. Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls. PLOS ONE (2018).
5. Elevated Polyamines in Saliva of Pancreatic Cancer. Cancers (2018).